Full Report - Research for Development - Department for ...

Author
(year)
(IV)/(EV) and
settings
Le Fevre
(2010)
(++)/(+)
Bangladesh
Intervention
(I) and
comparator
(C)
I: Topical
emollients –
synthetic
Aquaphor or
sunflower
seed oil
C: No
treatment
Target
population
and duration
of economic
analysis
497 low
birthweight
babies <
1,500 g. Preterm
infants
only receiving
hospital care
within 72
hours of
birth.
28 days
Study
design
RCT
CEA
Cost results Mortality-related
effectiveness results
Annualised total
intervention
costs for
programme,
including startup
costs
US$1,834.
Average cost
per patient in
Aquaphor, SSO
and No
treatment
groups were
$125.35, $99.47
and $93.39
respectively. P
values not
reported.
26% reduction in
mortality with SSO
compared to no
treatment; or 523
years of life lost (YLL)
averted.
32% reduction in
mortality with
Aquaphor compared to
no treatment; or 649
YLL averted.
Perspective/price
year
Health sector
costs, including
start-up costs
US$ 2006 prices
Appendix 4.8
Synthesis of
costs and
effectiveness
data
For SSO,
incremental cost
compared to no
treatment of US$
61 per death
averted or $2.15
per YLL averted.
For Aquaphor
incremental cost
compared to no
treatment of US$
162 per death
averted or $5.74
per YLL averted.
What are the effects of different models of delivery for improving maternal and infant health outcomes for poor people in urban areas in low income
and lower middle income countries?
235